Maite
Maite Agüeros Bazo, Pamplona-Navarra ES
Patent application number | Description | Published |
---|---|---|
20100136129 | NANOPARTICLES COMPRISING A CYCLODEXTRIN AND A BIOLOGICALLY ACTIVE MOLECULE AND USES THEREOF - The invention relates to nanoparticles comprising a biodegradable polymer, a cyclodextrin or a derivative thereof, and a biologically active molecule. Said nanoparticles can associate large amounts of biologically active molecules, especially of a hydrophobic nature, and release the biologically active molecule providing sustained and constant plasma levels thereof when they are administered orally or through any other mucosa of the organism. | 06-03-2010 |
20130116261 | NANOPARTICLES FOR ENCAPSULATION OF COMPOUNDS, THE PRODUCTION AND USES THEREOF - The present invention relates to nanoparticles for the encapsulation of compounds, the obtaining and uses thereof. The nanoparticles comprise a zein matrix and a basic amino acid. Said nanoparticles can encapsulate a water-soluble or fat-soluble biologically active compound. It is applicable in the food, pharmaceutical and cosmetic sectors and in the nanotechnology sector. | 05-09-2013 |
20130209530 | "NANOPARTICLES FOR THE ENCAPSULATION OF COMPOUNDS, PREPARATION THEREOF AND USE OF SAME" - The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, comprising a casein matrix, a basic amino acid and a metal selected from a divalent metal, a trivalent metal and combinations thereof. Said nanoparticles can encapsulate a water soluble or fat soluble biologically active compound. The invention is applicable in the food, pharmaceutical and cosmetic sectors and in the nanotechnology sector. | 08-15-2013 |
Maite Agüeros Bazo, Pamplona-Navarra ES
Patent application number | Description | Published |
---|---|---|
20100136129 | NANOPARTICLES COMPRISING A CYCLODEXTRIN AND A BIOLOGICALLY ACTIVE MOLECULE AND USES THEREOF - The invention relates to nanoparticles comprising a biodegradable polymer, a cyclodextrin or a derivative thereof, and a biologically active molecule. Said nanoparticles can associate large amounts of biologically active molecules, especially of a hydrophobic nature, and release the biologically active molecule providing sustained and constant plasma levels thereof when they are administered orally or through any other mucosa of the organism. | 06-03-2010 |
20130116261 | NANOPARTICLES FOR ENCAPSULATION OF COMPOUNDS, THE PRODUCTION AND USES THEREOF - The present invention relates to nanoparticles for the encapsulation of compounds, the obtaining and uses thereof. The nanoparticles comprise a zein matrix and a basic amino acid. Said nanoparticles can encapsulate a water-soluble or fat-soluble biologically active compound. It is applicable in the food, pharmaceutical and cosmetic sectors and in the nanotechnology sector. | 05-09-2013 |
20130209530 | "NANOPARTICLES FOR THE ENCAPSULATION OF COMPOUNDS, PREPARATION THEREOF AND USE OF SAME" - The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, comprising a casein matrix, a basic amino acid and a metal selected from a divalent metal, a trivalent metal and combinations thereof. Said nanoparticles can encapsulate a water soluble or fat soluble biologically active compound. The invention is applicable in the food, pharmaceutical and cosmetic sectors and in the nanotechnology sector. | 08-15-2013 |
Maite Brandt-Pearce, Free Union, VA US
Patent application number | Description | Published |
---|---|---|
20150147069 | EXPURGATED PULSE POSITION MODULATION FOR COMMUNICATION - An expurgated pulse position modulation (EPPM) technique can be used to encode information for wireless transmission. Such an EPPM technique can be compatible with a simple receiver architecture, such as including a shift register and pulse position modulation (PPM) decoder. A multi-level EPPM (MEPPM) approach can increase the available symbols in the modulation constellation and can be used to accommodate multiple users or devices concurrently. Interleaving techniques can be used such as to reduce inter-symbol interference. An optical transmitter and an optical receiver can be used, such as including using energy in a visible range of frequencies. In an example, an optical source such as including one or more light emitting diodes can provide visible light for illumination, and the EPPM technique can include using codewords specified to provide a desired dimming level when such codewords are used to intensity modulate the optical source, without perceptible flicker. | 05-28-2015 |
Maite Burrel Diez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20150331633 | METHOD AND SYSTEM OF CACHING WEB CONTENT IN A HARD DISK - A method and system of storing and retrieving web content in a cache hard disk memory, in which read requests and write requests are separated in two different queues, and read requests are prioritized. This way, write requests are selectively delayed to favour read operations and improve user experience. | 11-19-2015 |
Maite Del Olmo Basterrechea, Derio ES
Patent application number | Description | Published |
---|---|---|
20120135445 | CELL TRANSPORT SYSTEM - The present invention relates to a system for cell transport Said system allows the transport of cells, assuring their integrity and viability during the entire transport process. It consists of a system suitable for a wide variety of formats which allows a broad range of technical applications of the system The system of the invention allows providing ready-to-use cells, without the cells having to be manipulated before they are used by technical experts in cell biology The invention particularly relates to an agarose plus agarase mixture covering or enveloping, depending on the format of the selected transport system, the cell culture, protecting it during the transport process, as well as to the methodology of cell recovery of the cells transported in the system. | 05-31-2012 |
Maite Del Olmo Basterrechea, Sopelana (bizkaia) ES
Patent application number | Description | Published |
---|---|---|
20130095143 | BIOMATERIAL FROM WHARTON'S JELLY UMBILICAL CORD - The present invention relates to a biomaterial, specifically a hydrogel, based on the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans present exclusively in the Wharton's jelly of the umbilical cord (which can optionally be combined with cells as a combination therapy), and also to the methods for the production and use thereof. | 04-18-2013 |
Maite Del Olmo Basterrechea, Sopelana ES
Patent application number | Description | Published |
---|---|---|
20110158963 | THREE-DIMENSIONAL MATRICES OF STRUCTURED POROUS MONETITE FOR TISSUE ENGINEERING AND BONE REGENERATION, AND METHOD OF THE PREPARATION THEREOF - The present invention is comprised within tissue engineering and, specifically, within bone regeneration. The invention relates to a porous three-dimensional matrix of monetite which is biocompatible, has structured porosity and is predefined and reabsorbable, as well as to the method of synthesis capable of producing said material and the applications thereof. These matrices are a perfect base for cell colonization and proliferation, allowing the application thereof in tissue engineering and bone regeneration as a result of their advantageous properties of biocompatibility, reabsorption, osteoinduction, revascularization, etc. | 06-30-2011 |
20110256186 | BIOMATERIAL BASED ON WHARTON'S JELLY FROM THE HUMAN UMBILICAL CORD - The present invention relates to a biomaterial, specifically a hydrogel, formed from the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans isolated exclusively from the Wharton's jelly of the umbilical cord which can optionally contain cells, and also to the methods for the production and use thereof. | 10-20-2011 |
20130095049 | ANTIOXIDANT COMPOSITION - The present invention relates to an antioxidant composition comprising a combination of galatomannan and N-acetyl cysteine for its use in the treatment of a skin disease or condition resulting from reactive oxygen species production in the skin or involving reactive oxygen species production in the skin, to a hydrogel containing said combination as well as to dressing wounds comprising said hydrogel and its use in the healing of ulcers, wounds, burns and scalds. | 04-18-2013 |
Maite Diago López, Sevilla ES
Patent application number | Description | Published |
---|---|---|
20140373830 | CONFIGURATION OF THE RECEIVERS IN CONCENTRATED SOLAR PLANTS WITH TOWERS - The invention relates to a configuration of the receivers in concentrated solar plants with towers comprising at least one medium-temperature receiver ( | 12-25-2014 |
20150204315 | METHOD FOR OPERATING A THERMOELECTRIC SOLAR PLANT - Method of operating a solar thermoelectric power plant that allows operation of high-, medium- and low-pressure superheating turbines with both superheated steam and saturated steam. The plant includes energy storage in high-pressure liquid tanks. The method described allows the direct introduction of saturated steam into a superheated steam turbine. This steam may receive an intermediate reheating between the high-pressure turbine and the low- and medium-pressure turbines to achieve conditions of superheated steam. The mode of operation proposed in the invention facilitates the operation of the plant in periods without sunshine (during transient periods, such as passing clouds or night time) or during discharge of accumulators (saturated liquid tanks at high-pressure). | 07-23-2015 |
Maite Forment Tarrega, Madrid ES
Patent application number | Description | Published |
---|---|---|
20140056123 | SYSTEM AND METHOD OF FAILURE HANDLING IN A RADIO ACCESS NETWORK - Method and system of failure handling in a radio access network that minimizes the recovery time when a core node fails by storing the routing information of the core node and, whenever said core node fails, loading the routing information in an auxiliary node with the same hardware and software configuration as the core node. The traffic received at the core node is then routed to the auxiliary node through a physical connection that is transparent to the radio access network. The amount of routing information required by this system is minimal, and thus the recovery time is greatly reduced. | 02-27-2014 |
Maite Insausti Peña, Leioa-Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20120315480 | COPPER NANOPARTICLES WITH MAGNETIC PROPERTIES - The present invention relates to thiol- or an amine-associated ferromagnetic or superparamagnetic copper nanoparticles with an average diameter less than 30 nm, to the method for obtaining them and their applications in biomedicine and other fields. | 12-13-2012 |
Maite Insausti Peña, Leioa-Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20120315480 | COPPER NANOPARTICLES WITH MAGNETIC PROPERTIES - The present invention relates to thiol- or an amine-associated ferromagnetic or superparamagnetic copper nanoparticles with an average diameter less than 30 nm, to the method for obtaining them and their applications in biomedicine and other fields. | 12-13-2012 |
Maite Noizet, Versailles FR
Patent application number | Description | Published |
---|---|---|
20150087527 | METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF TISSUE OR ORGAN FIBROSIS IN A REPARATIVE OR REACTIVE PROCESS - The invention relates to methods of diagnosis or prognosis of a tissue or organ fibrosis (e.g., skin fibrosis, hypertrophic scar or a keloid) in a reparative or reactive process comprising the step of determining the levels of expression of genes encoding different molecular markers in a sample of a tissue or organ from a mammalian, wherein different genes markers are studied. | 03-26-2015 |
20150126447 | METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF WOUNDS - The present invention relates to a method and kit for the classification and prognosis of wounds of mammalian, in particular in human. The method defines a molecular signature that enables one to characterize a pathological wound healing such as chronic or non-healing wound. | 05-07-2015 |
Maite Rielland, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140057961 | SIN3B COMPLEX INHIBITION AND USE THEREOF IN THE PREVENTION OF PRO-ONCOGENIC INFLAMMATION AND CANCER - Methods for inactivating Sin3B and its associated activities to prevent, inhibit or attenuate pro-oncogenic inflammation and cancer progression, in particular pancreatic cancer progression are provided. | 02-27-2014 |
Maite Sylla-Iy Arreta Veitia, Paris FR
Patent application number | Description | Published |
---|---|---|
20120142658 | THERAPEUTICAL USE OF TERNARY COMPLEXES OF VALPROIC ACID - A method of treating a human subject having a condition responsive to valproic acid therapy, includes administering to the subject an effective amount of a metal-based ternary complex of valproic acid with nitrogen donor ligands, in particular with diimines or diamines. | 06-07-2012 |
Maite Tarre Perez, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20120101159 | IBUPROFEN LYSINATE ORAL SUSPENSION - The present invention refers to an ibuprofen lysinate-based pharmaceutical composition in the form of oral suspension and to the preparation procedure thereof. | 04-26-2012 |
Maite Zazpe Cenoz, Sevilla ES
Patent application number | Description | Published |
---|---|---|
20150159179 | METHOD FOR PRODUCING BIOFUELS AND FOOD CO-PRODUCTS USING EXTRACTS OF MICROALGAE CULTURES - The present invention relates to a method for the production of biofuels and food co-products which, thanks to the addition of microalgae culture extracts, optimizes the production of biofuel, in terms of time and yield, and improves the protein composition of its co-products useful in the food industry, as compared to similar methods for the production of biofuel and co-products which do not use microalgae culture extracts. | 06-11-2015 |